ID: ALA3393633

Max Phase: Preclinical

Molecular Formula: C26H16Cl4N2O8S2

Molecular Weight: 690.37

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(O)CSc1ccc(C(=O)c2[nH]c(Cl)c(Cl)c2-n2c(C(=O)c3ccc(SCC(=O)O)cc3O)cc(Cl)c2Cl)c(O)c1

Standard InChI:  InChI=1S/C26H16Cl4N2O8S2/c27-14-7-15(23(39)12-3-1-10(5-16(12)33)41-8-18(35)36)32(26(14)30)22-20(28)25(29)31-21(22)24(40)13-4-2-11(6-17(13)34)42-9-19(37)38/h1-7,31,33-34H,8-9H2,(H,35,36)(H,37,38)

Standard InChI Key:  KGQRYDIHKSMFFL-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 690.37

Molecular Weight (Monoisotopic): 687.9102

AlogP: 6.65

#Rotatable Bonds: 11

Polar Surface Area: 169.92

Molecular Species: ACID

HBA: 9

HBD: 5

#RO5 Violations: 2

HBA (Lipinski): 10

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 2.86

CX Basic pKa:

CX LogP: 6.90

CX LogD: -0.92

Aromatic Rings: 4

Heavy Atoms: 42

QED Weighted: 0.08

Np Likeness Score: -0.31

References

1. Li R, Cheng C, Balasis ME, Liu Y, Garner TP, Daniel KG, Li J, Qin Y, Gavathiotis E, Sebti SM..  (2015)  Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.,  90  [PMID:25437618] [10.1016/j.ejmech.2014.11.035]

2. Wan Y, Dai N, Tang Z, Fang H..  (2018)  Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.,  146  [PMID:29407973] [10.1016/j.ejmech.2018.01.076]

Source

Source(1):

• Scientific Literature